Migraine Treatment: Medication Overuse Headache
A review examined risk of medication overuse headache across classes of acute migraine treatments.
Sphenopalatine Ganglion Block: Pediatric Migraine
SPG is known to be an effective treatment among adults with migraine, but little is known about its use in the pediatric population.
Neuromodulation to Treat Cluster Headaches
Researchers tested the efficacy of neuromodulation of the sphenopalatine ganglion to treat patients with drug-refractory cluster headaches.
Pediatric Migraine: Cognitive Behavioral Therapy
Cognitive behavioral therapy to treat migraine in children and adolescents proved beneficial, but were the results long-lasting?
Manual Therapy Intervention for Migraine
A trial of chiropractic spinal manipulative therapy (CSMT) to treat migraine successfully blinded its patients to the trial intervention.
Migraine History Impacts Ischemic Stroke Risk
Perioperative stroke is associated with a significantly increased risk for mortality and long-term morbidities. What role does migraine history play?
Rosacea May Increase Migraine Risk
Research has linked rosacea with other neurologic conditions such as Parkinson disease and MS, but an association with migraine has been unclear.
Efficacy of Pediatric Migraine Drugs
There is no FDA-approved drug for pediatric migraine in children aged younger than 12, so treatment is consensus-based rather than evidence-based.
Do Migraine Patients Reach Sustained Pain Relief?
Achieving pain freedom at 2 hours and sustained pain response at 24 hours are important outcomes of any acute migraine therapy.
Nerve Blocks for Headaches & Migraine
Nerve blocks are often used in adults and children to treat headaches, but few data look at practice patterns in a pediatric setting.
By clicking Accept, you agree to become a member of the UBM Medica Community.